EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc., announced today the appointment of Robert Stein, MD, PhD, as Chief Executive Officer of the Company, effective August 1, 2008, and Member of its Board of Directors. KineMed is a leader in translational medicine-based drug development. Its business model is to acquire and advance drugs to treat atherosclerosis by enhancing the body’s process of removing cholesterol from tissues and from the body.